Nuclear Import of the MUC1-C Oncoprotein is Mediated by Nucleoporin Nup62
Overview
Affiliations
The MUC1 heterodimeric transmembrane protein is aberrantly overexpressed by most human carcinomas. The MUC1 C-terminal subunit (MUC1-C) is devoid of a classical nuclear localization signal and is targeted to the nucleus by an unknown mechanism. The present results demonstrate that MUC1-C associates with importin beta and not importin alpha. The results also show that, like importin beta, MUC1-C binds to Nup62 (nucleoporin p62). MUC1-C binds directly to the Nup62 central domain and indirectly to the Nup62 C-terminal alpha-helical coiled-coil domain. We demonstrate that MUC1-C forms oligomers and that oligomerization is necessary for binding to Nup62. The MUC1-C cytoplasmic domain contains a CQC motif that when mutated to AQA abrogates oligomerization and binding to Nup62. Stable expression of MUC1 with the CQC --> AQA mutations was associated with targeting to the cell membrane and cytosol and attenuation of nuclear localization. The results further show that expression of MUC1(CQC-AQA) attenuates MUC1-induced (i) transcriptional coactivation, (ii) anchorage-independent growth, and (iii) tumorigenicity. These findings indicate that the MUC1-C oncoprotein is imported to the nucleus by a pathway involving Nup62.
Godet I, Oza H, Shi Y, Joe N, Weinstein A, Johnson J Nat Commun. 2024; 15(1):8416.
PMID: 39341835 PMC: 11438863. DOI: 10.1038/s41467-024-51995-2.
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression.
Bhattacharya A, Wang K, Penailillo J, Chan C, Fushimi A, Yamashita N Oncogene. 2024; 43(28):2199-2214.
PMID: 38802648 PMC: 11226401. DOI: 10.1038/s41388-024-03068-3.
Aljabban J, Syed S, Syed S, Rohr M, Mukhtar M, Aljabban H Heliyon. 2023; 9(7):e17298.
PMID: 37539132 PMC: 10394915. DOI: 10.1016/j.heliyon.2023.e17298.
Zhao X, Zhang J, Zhang W, Guo Z, Wei W, Wang X Chem Sci. 2023; 14(5):1114-1122.
PMID: 36756328 PMC: 9891362. DOI: 10.1039/d2sc06171f.
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells.
Morimoto Y, Yamashita N, Daimon T, Hirose H, Yamano S, Haratake N J Immunother Cancer. 2023; 11(2).
PMID: 36754452 PMC: 9923360. DOI: 10.1136/jitc-2022-006238.